Theodore C Goldstein, Ronald G Martinez, Paul Rubin: Trusted agent for electronic commerce. The Brodia Group, Michael A Glenn, Kirk Wong, April 23, 2002: US06378075 (136 worldwide citation)

A trusted agent server provides a networked application that assists a customer in managing their online commercial affairs. A user contacts the server using a network access device, such as a browser on a personal computer. The trusted agent client component augments the user's network access ...

Keith R McNally, Ken Rogers, Paul Rubin: Information management and synchronous communications system with menu generation, and handwriting and voice modification of orders. Ameranth Wireless, Morgan & Finnegan L, January 3, 2006: US06982733 (99 worldwide citation)

An information management and synchronous communications system and method facilitates database equilibrium and synchronization with wired, wireless and Web-based systems, user-friendly and efficient generation of computerized menus and reservations with handwritten/voice modifications for restauran ...

Yun Gao, Paul Rubin, Nie Xiaoyi, Charles M Zepp: Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof. Foley Hoag & Eliot, June 27, 2002: US20020082268-A1

The present invention relates to compounds capable of inhibiting leukotriene activity and histamine activity, and their use in treating asthma and allergic conditions such as hay fever, dermatitus, and urticaria. Inhibition of both pathways permits more effective treatment of conditions with fewer s ...

Mark G Currie, Tom Jerussi, Paul Rubin, Chris H Senanayake: Compositions and methods for management of serotonin-mediated disorders. Ropes & Gray, May 1, 2003: US20030083338-A1

The present invention provides methods and compositions for conjoint administration of a nefazodonoid and a fluoxetinoid for the treatment of depression and other neurological conditions.

Charles M Zepp, Donald L Heefner, Paul Rubin, Mark G Currie: Compositions and methods for treating or preventing hearing impairment. Sepracor, Fish & Neave Ip Group, Ropes & Gray, May 12, 2005: US20050101534-A1

Ototoxic side-effects have either limited the application of an important group of antibiotics, aminoglycoside antibiotics, or have added further burden to those who have to resort to platinum-containing antineoplastic agents to treat life-threatening tumors. The present invention discloses pharmace ...